Multiple Myeloma

Conditions and Indications

Recognizing the Warning Signs

Identifying the signs of multiple myeloma can be challenging because the early symptoms are often vague and easily mistaken for less serious conditions, such as aging or general fatigue. However, recognizing these indications early is the most critical step toward effective treatment and successful stem cell transplantation.

At Liv Hospital, we believe that an informed patient is an empowered patient. Understanding the specific signals your body is sending from persistent bone pain to unexplained exhaustion can lead to a faster diagnosis and a more personalized treatment plan. This guide details the clinical conditions associated with multiple myeloma, explaining the “CRAB” criteria used by doctors worldwide and helping you distinguish between routine aches and signs that require immediate medical attention.

What Are the Early Signs of Multiple Myeloma?

In the earliest stages, multiple myeloma may not cause any symptoms at all. This is often referred to as “smoldering” or “asymptomatic” myeloma. However, as the plasma cells continue to multiply in the bone marrow, they begin to crowd out healthy blood cells and produce abnormal proteins that affect various organs.

The most common early complaints usually involve:

• Persistent Fatigue: Feeling tired even after a full night’s sleep, often due to anemia.
• Bone Pain: A dull, aching pain, most commonly in the back, ribs, or hips, that worsens with movement.
• Recurrent Infections: Getting sick frequently (e.g., pneumonia or sinus infections) because the immune system is compromised.

If you are experiencing these symptoms for more than a few weeks without a clear cause, it is essential to undergo a clinical evaluation.

Understanding the CRAB Criteria

Doctors use a specific set of clinical indicators, known by the acronym CRAB, to determine if multiple myeloma is active and requires immediate treatment. The presence of one or more of these conditions is often the deciding factor in moving from “observation” to “intervention.”

C – Calcium Elevation (Hypercalcemia)

When myeloma cells damage the bones, calcium is released into the bloodstream. High levels of calcium (hypercalcemia) can be dangerous and cause distinct symptoms:

• Extreme thirst and frequent urination.
• Severe constipation and nausea.
• Confusion, “brain fog,” or extreme drowsiness.
• Muscle weakness.

R – Renal (Kidney) Dysfunction

The abnormal antibody proteins (M proteins) produced by myeloma cells can clog the kidneys’ filtering system, leading to a condition often called “myeloma kidney.”

• Signs: Swelling in the legs (edema), foamy urine, fatigue, and weakness due to waste buildup in the blood.

A – Anemia

As myeloma cells take over the bone marrow, there is less room for the production of red blood cells.

• Signs: Shortness of breath during mild activity, dizziness, pale skin, and rapid heartbeat.

B – Bone Abnormalities

This is the most common indication, affecting nearly 85% of patients. Myeloma cells produce chemicals that speed up the breakdown of old bone and slow down the formation of new bone.

• Lytic Lesions: These are “punched-out” soft spots in the bone that appear on X-rays.
• Pathologic Fractures: Bones become so fragile that they break with minor stress, such as coughing or stepping off a curb.
• Spinal Compression: Collapsed vertebrae can press on the spinal cord, causing severe back pain, numbness, or muscle weakness in the legs.

Other Clinical Indications and Complications

Beyond the CRAB criteria, multiple myeloma can manifest in other ways that affect a patient’s quality of life and treatment eligibility.

Hyperviscosity Syndrome

In some cases, the level of M protein in the blood becomes so high that it thickens the blood (like syrup), making it difficult to circulate through small blood vessels.

• Symptoms: Blurred vision, nosebleeds, headaches, dizziness, and numbness in the extremities. This is a medical emergency that requires immediate attention.

Amyloidosis

Rarely, the antibody proteins produced by myeloma cells can link together to form a sticky substance called amyloid. This substance can deposit in organs like the heart, kidneys, and nerves, causing them to stiffen and malfunction.

• Symptoms: Irregular heartbeat, enlarged tongue, and numbness or tingling in the hands and feet (neuropathy).

Recurrent Infections

Because the cancerous plasma cells do not make functional antibodies, the body loses its primary defense against viruses and bacteria. Patients often find themselves battling the same infection repeatedly or taking longer than normal to recover from a cold.

Expert Evaluation at Liv Hospital

At Liv Hospital, we specialize in distinguishing between complex blood disorders. We understand that waiting for answers is the hardest part. Our international patient program is designed to expedite the evaluation process.

Upon arrival, patients with suspected myeloma undergo a comprehensive review of their symptoms. We focus not just on the cancer, but on stabilizing the complications treating the kidney function, managing bone pain, and correcting calcium levels before moving to long-term therapies like autologous stem cell transplantation.

When Should You See a Doctor?

Muscle pain and fatigue are common in everyday life, so how do you know when it’s serious? You should consult a specialist if you experience:

• Bone pain that is persistent, unexplained, and does not improve with rest.
• Sudden, severe back pain (which could indicate a collapsed vertebra).
• Unexplained weight loss accompanied by nausea or loss of appetite.
• Frequent infections or fevers without a clear cause.
• Numbness or weakness in your legs (a sign of spinal cord compression).

Risk Stratification: Standard vs. High-Risk Indications

Not all multiple myeloma cases behave the same way. Part of evaluating your condition involves determining if you have “Standard Risk” or “High Risk” myeloma. This is based on specific genetic markers found in the plasma cells.

• Standard Risk: The disease is likely to grow more slowly and respond well to standard treatments like stem cell transplants.
• High Risk: The disease may be more aggressive and requires a more intensive, novel therapy approach.

Determining your risk level is crucial because it dictates the urgency and type of treatment you will receive.

Diagnosis and Evaluation

Precision Testing for Personalized Care

Receiving a potential diagnosis of multiple myeloma can be a time of intense anxiety and uncertainty. Accurate diagnosis is the cornerstone of effective treatment; it determines not just if you have the condition, but specifically which type and how aggressive it might be.

At Liv Hospital, we utilize a comprehensive, multi-step diagnostic approach. We move beyond simple blood tests to employ advanced genetic profiling and high-resolution imaging. This allows our multidisciplinary team of hematologists and pathologists to construct a detailed “roadmap” of the disease, ensuring that your treatment plan whether it involves novel drug therapies or stem cell transplantation is perfectly tailored to your unique biological profile.

This guide explains the specific tests used to confirm multiple myeloma, what to expect during a bone marrow biopsy, and how doctors determine the stage of the disease.

Why Are Genetic Tests (FISH and Cytogenetics) Important?

Diagnosing multiple myeloma is no longer just about confirming the cancer; it is about understanding its genetic behavior. This is called Risk Stratification.

Once the bone marrow sample is obtained, we perform Fluorescence In Situ Hybridization (FISH) and Cytogenetic Analysis. These advanced tests look for specific chromosomal changes in the myeloma cells, such as:

• Translocations: Parts of chromosomes swapping places (e.g., t(4;14)).
• Deletions: Missing parts of chromosomes (e.g., del(17p)).

Why This Matters: Patients with “High-Risk” genetic markers may require more aggressive initial therapy or a tandem stem cell transplant, while “Standard-Risk” patients may respond excellently to conventional protocols. This personalized genetic insight is vital for long-term success.

How Do Imaging Tests Reveal Bone Damage?

Myeloma cells can weaken bones, causing “lytic lesions” (soft spots) or fractures that might not be immediately painful. Accurate imaging helps us see the extent of the disease throughout the skeleton.

• Low-Dose Whole Body CT: This has largely replaced standard X-rays because it provides a much more detailed 3D view of the bones and can detect smaller lesions.
• MRI (Magnetic Resonance Imaging): An MRI is highly sensitive and is used to detect myeloma in the spine or pelvis, especially if the doctor suspects the cancer is pressing on the spinal cord.
• PET-CT Scan: This combines metabolic and anatomical imaging. It highlights areas of active cancer growth (which light up on the scan) throughout the entire body. It is crucial for determining the stage of the disease and checking how well the treatment is working later on.

How Is Multiple Myeloma Detected via Blood and Urine?

The diagnostic journey often begins with blood work. Unlike solid tumors that form a lump, multiple myeloma is a cancer of the plasma cells in the blood and marrow. Therefore, the chemical signature of the disease is often found circulating in your system.

Key Laboratory Tests:

• Serum Protein Electrophoresis (SPEP): This is the primary screening test. It separates proteins in the blood to find the abnormal “M protein” (monoclonal protein) produced by myeloma cells. A spike in this protein is a strong indicator of the disease.
• Immunofixation Electrophoresis (IFE): This test is more sensitive than SPEP and identifies the exact type of abnormal antibody (e.g., IgG, IgA) being produced.
• Serum Free Light Chain Assay: Sometimes, myeloma cells don’t produce a full M protein but only small pieces called “light chains.” This test measures these chains to detect myeloma that SPEP might miss.
• Beta-2 Microglobulin (β2M): A high level of this protein indicates a more advanced stage of the disease and helps doctors predict the prognosis.
• Urine Tests (UPEP): Doctors analyze a 24-hour urine sample to check for “Bence Jones proteins,” which are light chains that have been filtered by the kidneys.

What Happens During a Bone Marrow Biopsy?

While blood tests provide strong clues, a bone marrow biopsy is the “gold standard” for a definitive diagnosis. We understand that the thought of this procedure can be frightening for many patients. At Liv Hospital, we prioritize your comfort, using local anesthesia and sedation options to minimize discomfort.

The Procedure Steps:

1. Aspiration: A thin needle is used to withdraw a liquid sample of the bone marrow, usually from the back of the hip bone (pelvis).
2. Biopsy: A slightly larger needle removes a small core of solid bone marrow tissue.
3. Pathology Review: Our expert hematopathologists examine the samples under a microscope to calculate the percentage of plasma cells. (In healthy marrow, plasma cells are less than 5%; in multiple myeloma, they are typically more than 10%).

This procedure is quick, typically taking less than 20 minutes, and is performed on an outpatient basis.

Liv Hospital’s Diagnostic Advantage

Time is often a critical factor for international patients. At Liv Hospital, our diagnostic infrastructure is designed for speed and accuracy.

• Rapid Results: Our on-site pathology and genetic labs reduce waiting times significantly, often providing preliminary results within 24-48 hours.
• Tumor Council: Every multiple myeloma case is reviewed by a multidisciplinary board, ensuring that your diagnosis is evaluated by hematologists, radiologists, and pathologists collaboratively.

How Is Multiple Myeloma Staged?

Staging helps the medical team understand how much cancer is in the body and the likely prognosis. Multiple Myeloma is staged using the Revised International Staging System (R-ISS), which combines three factors:

1. Blood markers: Levels of Beta-2 microglobulin and Albumin.
2. Genetics: Presence of high-risk chromosomal abnormalities (from FISH tests).
3. LDH Levels: Lactate Dehydrogenase levels in the blood.

The Stages:

• Stage I: Low levels of beta-2 microglobulin, normal albumin, no high-risk genetics. The outlook is excellent.
• Stage II: Intermediate levels; falling between Stage I and III.
• Stage III: High levels of beta-2 microglobulin, high-risk genetics, or high LDH. This indicates aggressive disease requiring immediate, intensive management.

Treatment and Procedures

Advanced Care & Stem Cell Therapies

The landscape of Multiple Myeloma treatment has undergone a revolutionary transformation in the last decade. What was once considered a rapidly progressing disease is now manageable for many patients as a chronic condition, thanks to the introduction of novel agents, immunotherapies, and advanced stem cell transplantation techniques.

At Liv Hospital, our goal goes beyond just symptom management. We aim for “deep remission” , a state where no cancer cells can be detected in the body. By combining the latest FDA-approved drug protocols with our world-class bone marrow transplant infrastructure, we offer international patients access to the same high standards of care found in top US medical centers, often with faster accessibility.

This guide details the strategic phases of myeloma treatment, from the initial “induction” therapy to the life-saving potential of stem cell transplantation.

The Three Phases of Treatment

Treating multiple myeloma is rarely a one-step process. It typically follows a strategic timeline designed to reduce the tumor burden, eliminate residual cells, and maintain remission.

1. Induction Therapy: Rapidly killing the bulk of cancer cells using a combination of drugs.
2. Consolidation (Stem Cell Transplant): Using high-dose chemotherapy followed by a stem cell rescue to deepen the response.
3. Maintenance Therapy: Long-term, low-dose treatment to prevent the cancer from returning.

Induction Therapy: The First Line of Defense

For most newly diagnosed patients, treatment begins with “Induction Therapy.” This usually involves a “triplet” or “quadruplet” regimen, a cocktail of three or four different types of drugs working together to attack the cancer from different angles.

Common agents used in these combinations include:

• Proteasome Inhibitors (e.g., Bortezomib/Velcade): These drugs block the cellular machinery that breaks down proteins, causing myeloma cells to fill up with waste and die.
• Immunomodulatory Drugs (e.g., Lenalidomide/Revlimid): These oral medications harness your immune system to recognize and destroy cancer cells.
• Corticosteroids (e.g., Dexamethasone): High doses of steroids are surprisingly effective at killing myeloma cells and reducing inflammation.
• Monoclonal Antibodies (e.g., Daratumumab): These are lab-made proteins that bind specifically to markers on the surface of myeloma cells, flagging them for destruction by the immune system.

Autologous Stem Cell Transplantation (ASCT)

For eligible patients, an Autologous Stem Cell Transplant remains the “gold standard” of care in multiple myeloma treatment. It is not a surgery, but rather a complex procedure that allows doctors to use chemotherapy doses that are 5 to 10 times higher than normal.

Why is it necessary? 

Myeloma cells are sensitive to chemotherapy, but so is healthy bone marrow. Standard doses of chemotherapy are limited by the damage they cause to your blood production. By collecting your stem cells before the high-dose chemotherapy, we can “rescue” your bone marrow afterward.

The Procedure at Liv Hospital:

1. Mobilization & Harvest: We use medication to move stem cells from your bone marrow into your bloodstream, where they are collected via a machine (apheresis) and frozen.
2. Conditioning: You receive a high dose of chemotherapy (usually Melphalan) to wipe out the myeloma cells in your marrow.
3. Infusion: The stored stem cells are thawed and infused back into your vein like a blood transfusion.
4. Engraftment: Over the next 10-14 days, these cells travel to the bone marrow and begin producing new, healthy blood cells.

Immunotherapy and CAR T-Cell Therapy

For patients whose myeloma has relapsed (returned) or is refractory (stopped responding) to standard treatments, Liv Hospital offers access to cutting-edge immunotherapies.

CAR T-Cell Therapy: This is one of the most exciting advancements in cancer care. It involves taking the patient’s own T-cells (immune cells), genetically modifying them in a lab to recognize a specific protein on myeloma cells (BCMA), and infusing them back into the patient. These “supercharged” T-cells then hunt down and destroy the cancer.

Bispecific T-cell Engagers (BiTEs): These are “bridge” drugs that attach to both a cancer cell and a T-cell, pulling them together so the immune system can attack the cancer directly.

Radiation and Supportive Procedures

While drug therapies treat the whole body (systemic), local treatments are often needed to manage specific complications:

• Radiation Therapy: High-energy beams are used to target specific bone lesions that are causing severe pain or are at risk of fracture. It is also used if a tumor is pressing on the spinal cord.
• Vertebroplasty/Kyphoplasty: Minimally invasive procedures where bone cement is injected into a collapsed vertebra to stabilize the spine and relieve pain instantly.
• Bone Strengthening Agents: Drugs like bisphosphonates (Zometa) or denosumab are given monthly to strengthen bones and prevent fractures.

Managing Relapsed or Refractory Myeloma

It is common for multiple myeloma to return eventually. This is called a relapse. When this happens, our team at Liv Hospital is prepared with “Second-Line” and “Third-Line” protocols.

• Switching Drug Classes: If the cancer becomes resistant to one drug, we switch to another (e.g., from Bortezomib to Carfilzomib).
• Second Transplant: In some cases, a second autologous transplant or an allogeneic transplant (from a donor) may be considered.
• Clinical Trials: We actively participate in international research, giving patients access to new drugs before they are widely available.

Why Choose Liv Hospital for Myeloma Treatment?

Treating multiple myeloma requires more than just a doctor; it requires an ecosystem.

• Multidisciplinary Tumor Boards: Your case is discussed weekly by a team of hematologists, radiation oncologists, and pathologists.
• Infection Control: Our stem cell transplant unit is equipped with HEPA-filtered positive pressure rooms to protect you when your immune system is weakest.
• Holistic Support: We integrate pain management, nutritional counseling, and physical therapy into your treatment plan to maintain your quality of life.

Recovery and Follow-up

Living Well After Treatment

Reaching the recovery phase of multiple myeloma treatment especially after undergoing an autologous stem cell transplant is a major milestone. However, recovery is not a single event; it is an ongoing journey of healing, monitoring, and adapting to a “new normal.”

At Liv Hospital, we view recovery as a partnership that extends far beyond your discharge date. Whether you are recovering in one of our specialized suites in Istanbul or back home with your family, our comprehensive follow-up protocols ensure you remain supported. We focus on two main goals: maintaining your remission for as long as possible (using maintenance therapy) and managing the long-term effects of treatment to ensure the highest possible quality of life.

This guide outlines what to expect in the weeks, months, and years following your treatment, offering practical advice on lifestyle, hygiene, and emotional well-being.

What to Expect Immediately After Stem Cell Transplant?

If your treatment plan included an Autologous Stem Cell Transplant (ASCT), the first few months of recovery are critical. Your immune system is effectively “rebooting,” leaving you temporarily vulnerable to infections.

The “Engraftment” Phase: In the first 2-4 weeks post-transplant, the new stem cells migrate to your bone marrow and begin producing blood cells. During this time, you may experience:

• Fatigue: Extreme tiredness is the most common complaint and can persist for months.
• Gastrointestinal Issues: Nausea, loss of appetite, or diarrhea are common side effects of high-dose chemotherapy.
• Low Blood Counts: You will need frequent blood tests to monitor your platelets and red blood cells.

Gradually, as your counts recover, your energy will return. However, patience is key, rushing your body can lead to setbacks.

Protecting Yourself: Infection Prevention and Hygiene

Because multiple myeloma affects the plasma cells (your immune system’s defenders) and treatment suppresses immunity, infection prevention is the cornerstone of recovery.

Crucial Precautions for the First 100 Days:

• Hand Hygiene: Wash hands frequently with soap and warm water for at least 20 seconds.
• Avoid Crowds: Stay away from shopping malls, public transport, or anyone with a cold/flu.
• Masking: Wearing a high-quality face mask (N95 or KN95) is recommended in public spaces.
• Food Safety (Neutropenic Diet): Avoid raw meats, sushi, unpasteurized cheeses, and unwashed raw vegetables. Cooked foods are safer because heat kills bacteria.
• Pet Care: Avoid cleaning litter boxes or bird cages, as they can harbor dangerous fungi and parasites.

What Is Remission and How Do We Monitor It?

The goal of treatment is remission, a period where signs of cancer are reduced or undetectable. However, “remission” has different levels:

• Partial Response: The level of M protein in the blood has dropped by at least 50%.
• Very Good Partial Response: M protein is detectable only by highly sensitive tests.
• Complete Response: No M protein is found in standard tests.
• Stringent Complete Response: No plasma cells are found even in bone marrow biopsies.

Minimal Residual Disease (MRD) Testing: At Liv Hospital, we use advanced flow cytometry and genetic sequencing to look for MRD tiny traces of cancer cells that standard tests miss. Being “MRD Negative” is the deepest level of remission and a strong predictor of long-term survival.

Follow-Up Schedule: Typically, you will have check-ups every 1-3 months for the first year, then every 3-6 months. These visits include blood tests (SPEP, light chains) and occasionally bone marrow exams.

Maintenance Therapy: Keeping the Cancer Away

For most patients, treatment doesn’t stop completely after the transplant. To prevent the myeloma from returning (relapse), doctors prescribe Maintenance Therapy.

This usually involves taking a lower dose of a targeted drug, such as Lenalidomide (Revlimid), daily for an extended period often until the disease progresses. Studies show that maintenance therapy significantly extends survival.

Side Effect Management: Long-term use of these drugs can cause fatigue, cramps, or blood clots. Our team will adjust your dosage to balance cancer control with quality of life.

Managing Long-Term Side Effects

Survivorship involves managing the lingering effects of the disease and its treatment.

Peripheral Neuropathy: Drugs like Bortezomib can cause numbness, tingling, or pain in the hands and feet.

• Tip: Protect your feet with comfortable shoes, check water temperature with your elbow before bathing, and ask your doctor about supplements like B-complex vitamins (under supervision).

Bone Health: Myeloma weakens bones even in remission.

• Tip: You may continue receiving bone-strengthening infusions (bisphosphonates) monthly or quarterly. Gentle, weight-bearing exercise (like walking) helps strengthen bones, but high-impact activities should be avoided.

Chemo Brain: Many patients report mental fog or trouble concentrating.

• Tip: Engage in “brain games” like puzzles, keep a detailed calendar, and be patient with yourself. This usually improves over time.

Lifestyle: Nutrition, Exercise, and Mental Health

There is no specific “anti-myeloma diet,” but fueling your body correctly aids recovery. Focus on a plant-based diet rich in cooked vegetables, lean proteins, and whole grains to rebuild muscle and stamina.

Exercise: Movement is medicine. It combats fatigue and depression. Start with short, 10-minute walks and gradually increase. Swimming is excellent as it puts no stress on fragile bones.

Emotional Support: The fear of relapse (often called “scanxiety” before check-ups) is real. Joining a support group or speaking with a psycho-oncologist can provide essential coping strategies. You are not just a patient; you are a person with a life to live.

Liv Hospital’s Commitment to International Patients

We understand that returning home after treatment can feel daunting. Liv Hospital bridges the distance with technology.

• Telemedicine Consultations: We schedule regular video calls to review your local blood test results.
• Physician Coordination: We provide detailed discharge summaries and treatment protocols to your local oncologist, ensuring a seamless transition of care.
• Rapid Re-Entry: Should a relapse occur, your medical history is already with us, allowing for immediate planning of second-line therapies or clinical trials.